Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Humana Inc (HUM) vs MasTec Inc (MTZ) Price & Performance

Humana IncTrade
MasTec IncTrade

Price performance (Past 24H)

Key statistics

Humana Inc vs MasTec Inc — how do they compare? Humana Inc trades at $432 (market cap $46.49B), while MasTec Inc trades at $213.99 (market cap $17.40B). The key difference: Humana Inc is far larger — about 2.7× MasTec Inc's market cap, and Humana Inc pays a 0.91% dividend while MasTec Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and MasTec Inc for 23 Days on average.

HUMMTZ
Market Cap
$46.49B$17.40B
Volume
2,567,7041,415,821
Sector
HealthIndustrials
52-Week High
$409.85$437.51
52-Week Low
$163.67$190.08
Typical Hold Time
53 Days23 Days
Enterprise Value
$53.84B$20.32B
Dividend Yield
0.91%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Humana Inc

Humana (HUM) trades at $441.74, up 11.41% over 24 hours, reflecting strong momentum. The stock shows bullish technical signals with support at $391 and resistance at $406. Fundamentally, revenue grew to $129.66B in 2025, though net income margin compressed to 0.88%. Recent news highlights a Barclays upgrade to a $515 price target and upcoming Q3 earnings on November 6, 2026.

The outlook is cautiously optimistic with a consensus price target of $457.05 implying modest upside. Risks include margin pressure from Medicare Advantage plan changes and potential regulatory scrutiny. Institutional activity is mixed, with Bank of America adding a position while some funds reduced stakes.

MasTec Inc

MasTec (MTZ) trades at $223.37, down 2.16% on the day, with technical indicators showing a neutral to bearish short-term bias. The company demonstrates strong fundamentals with Q1 2026 earnings beating expectations and a robust 88.9% analyst buy rating. Recent news highlights MTZ's positioning to benefit from infrastructure investment cycles, particularly in power delivery and data center markets, supported by a record $21.4 billion backlog.

The outlook remains positive given strong institutional support and infrastructure tailwinds, though premium valuation and communications segment softness pose risks. With a consensus price target of $408.58 representing 83% upside potential, the stock offers significant growth opportunity for investors comfortable with execution risks in the competitive infrastructure sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HUM

No sentiment data available yet.

MTZ
98% Buy2% Sell
Avg holding period · 23 Days

Top news

Latest headlines on both assets

About Humana Inc

Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Read more on HUM →

About MasTec Inc

MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.

Read more on MTZ →